1. Home
  2. BLDE vs RENE Comparison

BLDE vs RENE Comparison

Compare BLDE & RENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLDE
  • RENE
  • Stock Information
  • Founded
  • BLDE 2014
  • RENE 2021
  • Country
  • BLDE United States
  • RENE United States
  • Employees
  • BLDE N/A
  • RENE N/A
  • Industry
  • BLDE Aerospace
  • RENE Blank Checks
  • Sector
  • BLDE Consumer Discretionary
  • RENE Finance
  • Exchange
  • BLDE Nasdaq
  • RENE Nasdaq
  • Market Cap
  • BLDE 276.7M
  • RENE 151.4M
  • IPO Year
  • BLDE N/A
  • RENE 2022
  • Fundamental
  • Price
  • BLDE $3.95
  • RENE $11.66
  • Analyst Decision
  • BLDE Buy
  • RENE
  • Analyst Count
  • BLDE 1
  • RENE 0
  • Target Price
  • BLDE $6.00
  • RENE N/A
  • AVG Volume (30 Days)
  • BLDE 1.6M
  • RENE 3.4K
  • Earning Date
  • BLDE 11-12-2024
  • RENE 01-01-0001
  • Dividend Yield
  • BLDE N/A
  • RENE N/A
  • EPS Growth
  • BLDE N/A
  • RENE 42.92
  • EPS
  • BLDE N/A
  • RENE 0.43
  • Revenue
  • BLDE $241,814,000.00
  • RENE N/A
  • Revenue This Year
  • BLDE $11.34
  • RENE N/A
  • Revenue Next Year
  • BLDE $5.73
  • RENE N/A
  • P/E Ratio
  • BLDE N/A
  • RENE $26.90
  • Revenue Growth
  • BLDE 12.04
  • RENE N/A
  • 52 Week Low
  • BLDE $2.45
  • RENE $10.93
  • 52 Week High
  • BLDE $5.17
  • RENE $11.67
  • Technical
  • Relative Strength Index (RSI)
  • BLDE 47.19
  • RENE 63.75
  • Support Level
  • BLDE $3.95
  • RENE $11.64
  • Resistance Level
  • BLDE $4.45
  • RENE $11.65
  • Average True Range (ATR)
  • BLDE 0.37
  • RENE 0.00
  • MACD
  • BLDE -0.08
  • RENE -0.00
  • Stochastic Oscillator
  • BLDE 11.45
  • RENE 87.50

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

About RENE Cartesian Growth Corporation II

Cartesian Growth Corp II is a blank check company.

Share on Social Networks: